
A groundbreaking topical gene therapy for 'butterfly skin disease' has transformed rare disease treatment. Suma Krishnan's innovative approach, applying genetic medicine directly to the skin, led to the FDA-approved Vyjuvek. This breakthrough, developed in her fifties, offers hope and a new era of targeted care for patients suffering from this painful inherited condition.
from Science News: Fresh Discoveries, Research & Breakthroughs https://ift.tt/6FUJWH3
via
IFTTT
0 Comments